2020 tables: Institutions - chemistry - corporate

The 2020 tables are based on Nature Index data from 1 January 2019 to 31 December 2019.

Table criteria

# Institution Share 2018 Share 2019 Count 2019 Change in Adjusted Share 2018-2019*
1 Merck & Co., Inc., United States of America (USA) 22.27 25.90 48 8.5%
2 AstraZeneca plc, United Kingdom (UK) 9.87 17.28 56 63.2%
3 Novartis International AG, Switzerland 6.74 14.91 35 106.4%
4 Toyota Group, Japan 3.37 12.75 24 253.0%
5 F. Hoffmann-La Roche AG, Switzerland 15.16 12.27 23 -24.5%
6 Bristol-Myers Squibb (BMS), United States of America (USA) 14.52 11.77 23 -24.4%
7 IBM Corporation, United States of America (USA) 20.94 11.19 23 -50.1%
8 Pfizer Inc., United States of America (USA) 12.07 9.16 26 -29.2%
9 Thermo Fisher Scientific Inc., United States of America (USA) 9.47 6.77 36 -33.4%
10 DowDuPont Inc., United States of America (USA) 10.06 6.60 34 -38.8%
11 China Shipbuilding Industry Corporation (CSIC), China 5.25 6.54 82 16.1%
12 Johnson & Johnson, United States of America (USA) 5.95 6.27 18 -1.7%
13 FiberHome Technologies Group, China 4.27 6.03 52 31.8%
14 GlaxoSmithKline plc. (GSK), United Kingdom (UK) 7.74 5.84 17 -29.6%
15 Waters Corporation, United States of America (USA) 2.40 5.13 13 98.9%
16 Bruker Corporation, United States of America (USA) 4.69 4.78 23 -5.1%
17 AbbVie Inc., United States of America (USA) 4.58 4.72 13 -3.9%
18 Samsung Group, South Korea 6.05 4.67 22 -28.1%
19 Jinchuan Group Co., Ltd., China 5.59 4.57 21 -23.7%
20 Exxon Mobil Corporation (ExxonMobil), United States of America (USA) 4.78 4.30 16 -16.1%
21 Eli Lilly and Company, United States of America (USA) 2.12 4.26 20 87.5%
22 Amgen Inc., United States of America (USA) 2.38 3.95 6 54.7%
23 C. H. Boehringer Sohn AG & Co. KG (Boehringer Ingelheim), Germany 4.08 3.85 8 -11.9%
24 BASF SE, Germany 6.41 3.64 22 -47.0%
25 Bayer AG, Germany 3.57 3.51 9 -8.1%
26 Shimadzu Corporation, Japan 3.23 3.49 7 0.6%
27 Shanghai Jiahua Poly Battery Technology Co., Ltd., China 3.58 3.23 10 -15.8%
28 UCB S.A., Belgium 4.20 3.20 15 -29.0%
29 Sinopec Corporation, China 1.05 3.09 11 174.3%
30 China National Tobacco Company (CNTC), China 1.27 3.01 7 121.5%
31 Koninklijke DSM N.V. (DSM), Netherlands 0.14 3.00 9 1,857.9%
32 Nippon Telegraph and Telephone Corporation (NTT), Japan 3.10 2.92 5 -12.1%
33 China National Chemical Corporation (ChemChina), China 2.97 2.88 14 -9.5%
34 Saudi Aramco, Saudi Arabia 1.36 2.83 9 94.2%
35 Vertex Pharmaceuticals Incorporated, United States of America (USA) 0.68 2.72 7 273.7%
36 Rigaku Corporation, Japan 2.09 2.63 15 17.4%
37 JEOL Ltd., Japan 2.35 2.54 18 0.8%
38 Regeneron Pharmaceuticals, Inc., United States of America (USA) 2.00 2.54 6 18.2%
39 Biogen Inc., United States of America (USA) 0.05 2.24 5 3,798.7%
40 Piramal Enterprises Limited, India 2.00 2.00 2 -6.7%
41 Synfuels China Technology Co., Ltd., China 2.52 1.90 11 -29.7%
42 Alnylam Pharmaceuticals, Inc., United States of America (USA) 1.79 2 N/A
43 Mitsubishi Group, Japan 1.56 1.75 10 4.4%
44 Sanofi, France 3.29 1.65 10 -53.1%
45 Ilika plc, United Kingdom (UK) 1.65 2 N/A
46 Takasago International Corporation, Japan 0.80 1.61 2 87.4%
47 Takeda Pharmaceutical Company Limited, Japan 2.10 1.60 3 -28.8%
48 BP plc, United Kingdom (UK) 0.40 1.59 4 270.6%
49 Ajinomoto Co., Inc., Japan 0.24 1.55 4 509.1%
50 Panasonic Corporation, Japan 1.50 1.55 4 -3.5%

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals, selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at nature.com/nature-index/.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.

*The change in adjusted Share accounts for the small annual variation in the total number of articles in Nature Index journals. Share values have been adjusted to 2021 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.